CES2 expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes

Michela Capello, Johannes F. Fahrmann, Mayrim V. Rios Perez, Jody V. Vykoukal, Ehsan Irajizad, Satyendra C. Tripathi, David Roife, Leonidas E. Bantis, Yaan Kang, Deepali L. Kundnani, Hanwen Xu, Laura R. Prakash, James P. Long, Hiroyuki Katayama, Alia Fleury, Sammy Ferri-Borgogno, Dodge L. Baluya, Jennifer B. Dennison, Clemente Aguilar-Bonavides, Julian P. CasabarMuge Celiktas, Kim Anh Do, Oliver Fiehn, Anirban Maitra, Huamin Wang, Ziding Feng, Paul J. Chiao, Matthew H. Katz, Jason B. Fleming, Samir M. Hanash

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'CES2 expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences